MCM
GMED icon

Maryland Capital Management’s Globus Medical GMED Stock Holding History

Maryland Capital Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,169
Closed -$234K – 230
2022
Q1 		$234K Sell
3,169
-163
-5% -$11.3K 0.01% 228
2021
Q4 		$241K Buy
3,332
+56
+2% +$4.07K 0.01% 240
2021
Q3 		$251K Buy
3,276
+601
+22% +$48.3K 0.02% 221
2021
Q2 		$207K Buy
+2,675
New +$190K 0.01% 251

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Maryland Capital Management's GMED Position: Q2 2022 in Review

Maryland Capital Management sold out of Globus Medical (GMED) in Q2 2022, closing a stake of 3,169 shares — an estimated $234K sold.

Maryland Capital Management first reported a position in GMED in Q2 2021 and held it in 4 quarters. The position peaked at $251K in Q3 2021. 364 funds tracked by Wall St. Rank hold GMED as of Q2 2022.

  • Maryland Capital Management reported no remaining Globus Medical position as of Q2 2022 after selling out during the quarter.
  • Maryland Capital Management sold 3,169 Globus Medical shares in Q2 2022, an estimated $234K.
  • Maryland Capital Management first reported a position in Globus Medical in Q2 2021 and held it in 4 quarters.
  • Maryland Capital Management's Globus Medical position peaked at $251K in Q3 2021.
  • 364 funds tracked by Wall St. Rank held Globus Medical as of Q2 2022.

Based on Maryland Capital Management's 13F filing for Q2 2022, filed 11 Aug 2022.